Efficacy of follow-up bone scans in carcinoma of the prostate
β Scribed by Doug Corrie; James H. Timmons; John M. Bauman; Ian M. Thompson
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 234 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Three hundred fifteen radioisotopic bone scans ranging from initial scan only to nine scans per patient, performed on 114 patients with adenocarcinoma of the prostate between 1979 and 1984, were reviewed. Seventeen patients had positive scans, ten on initial scan and seven at follow-up. Nine patients had bone pain at the time of the first positive scan and pain developed in two patients 6 months and 2 years later, respectively. The other six patients are still asymptomatic 1 to 4 years later. False-positive scans were found in six other patients. No patient with bone pain had a negative scan. We believe that routine bone scans for prostate cancer follow-up are not cost-effective unless the patient is symptomatic. Bone scans also are indicated for initial staging and to observe disease response to protocol treatment.
π SIMILAR VOLUMES
## BACKGROUND. A reliable imaging modality is required to uncover occult soft-tissue recurrence after failure of primary prostate cancer therapy. This retrospective study was done to evaluate the ability of the 111 Indium-labeled monoclonal antibody (ProstaScint) scan in detection of prostatic bed
We retrospectively studied four patients who were treated with vascularized iliac bone graft for reconstruction of the tibia. The average length of the graft was 9.8 cm. The follow-up period was 11-18 years (average, 14.8 years). Although two of them were osteomyelitis, no recurrence occurred. We al